6-(3-methyl-1-tritylpyrazol-4-yl)pyridine-3-carbonitrile结构式
|
常用名 | 6-(3-methyl-1-tritylpyrazol-4-yl)pyridine-3-carbonitrile | 英文名 | 6-(3-methyl-1-tritylpyrazol-4-yl)pyridine-3-carbonitrile |
---|---|---|---|---|
CAS号 | 857531-67-0 | 分子量 | 426.51200 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C29H22N4 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
英文名 | 6-(3-methyl-1-tritylpyrazol-4-yl)pyridine-3-carbonitrile |
---|---|
英文别名 | 更多 |
分子式 | C29H22N4 |
---|---|
分子量 | 426.51200 |
精确质量 | 426.18400 |
PSA | 54.50000 |
LogP | 5.96538 |
~51% 6-(3-methyl-1-t... 857531-67-0 |
文献:ASTEX THERAPEUTICS LIMITED; THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL; CANCER RESEARCH TECHNOLOGY LIMITED Patent: WO2006/136821 A1, 2006 ; Location in patent: Page/Page column 117-118 ; WO 2006/136821 A1 |
6-(3-methyl-1-trityl-1H-pyrazol-4-yl)-nicotinonitrile |
3-Pyridinecarbonitrile,6-[3-methyl-1-(triphenylmethyl)-1H-pyrazol-4-yl] |